PubRank

Birke Bartosch

Author PubWeight™ 47.67‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C. Proc Natl Acad Sci U S A 2007 3.13
2 Characterization of host-range and cell entry properties of the major genotypes and subtypes of hepatitis C virus. Hepatology 2005 2.93
3 Monoclonal antibody AP33 defines a broadly neutralizing epitope on the hepatitis C virus E2 envelope glycoprotein. J Virol 2005 2.85
4 Evidence for cross-genotype neutralization of hepatitis C virus pseudo-particles and enhancement of infectivity by apolipoprotein C1. Proc Natl Acad Sci U S A 2005 2.42
5 Characterization of functional hepatitis C virus envelope glycoproteins. J Virol 2004 2.40
6 Human serum facilitates hepatitis C virus infection, and neutralizing responses inversely correlate with viral replication kinetics at the acute phase of hepatitis C virus infection. J Virol 2005 2.30
7 Role of N-linked glycans in the functions of hepatitis C virus envelope glycoproteins. J Virol 2005 2.19
8 Analysis of a highly flexible conformational immunogenic domain a in hepatitis C virus E2. J Virol 2005 1.53
9 Neutralizing antibodies to hepatitis C virus (HCV) in immune globulins derived from anti-HCV-positive plasma. Proc Natl Acad Sci U S A 2004 1.53
10 Hepatitis C virus glycoproteins mediate low pH-dependent membrane fusion with liposomes. J Biol Chem 2005 1.41
11 C-type lectins L-SIGN and DC-SIGN capture and transmit infectious hepatitis C virus pseudotype particles. J Biol Chem 2004 1.41
12 Human monoclonal antibodies that react with the E2 glycoprotein of hepatitis C virus and possess neutralizing activity. Hepatology 2005 1.38
13 Receptor complementation and mutagenesis reveal SR-BI as an essential HCV entry factor and functionally imply its intra- and extra-cellular domains. PLoS Pathog 2009 1.36
14 The tight junction-associated protein occludin is required for a postbinding step in hepatitis C virus entry and infection. J Virol 2009 1.36
15 Vaccine-induced early control of hepatitis C virus infection in chimpanzees fails to impact on hepatic PD-1 and chronicity. Hepatology 2007 1.32
16 HCV and oxidative stress in the liver. Viruses 2013 1.28
17 The exchangeable apolipoprotein ApoC-I promotes membrane fusion of hepatitis C virus. J Biol Chem 2007 1.21
18 Basic residues in hypervariable region 1 of hepatitis C virus envelope glycoprotein e2 contribute to virus entry. J Virol 2005 1.21
19 Determinants of high titer in recombinant porcine endogenous retroviruses. J Virol 2004 1.04
20 Assembly of functional hepatitis C virus glycoproteins on infectious pseudoparticles occurs intracellularly and requires concomitant incorporation of E1 and E2 glycoproteins. J Gen Virol 2005 1.04
21 Contribution of the charged residues of hepatitis C virus glycoprotein E2 transmembrane domain to the functions of the E1E2 heterodimer. J Gen Virol 2005 1.01
22 Characterization of Lassa virus cell entry and neutralization with Lassa virus pseudoparticles. J Virol 2009 0.97
23 Xenotransplantation and pig endogenous retroviruses. Rev Med Virol 2003 0.96
24 Reduction of the infectivity of hepatitis C virus pseudoparticles by incorporation of misfolded glycoproteins induced by glucosidase inhibitors. J Gen Virol 2007 0.90
25 Very-low-density lipoprotein (VLDL)-producing and hepatitis C virus-replicating HepG2 cells secrete no more lipoviroparticles than VLDL-deficient Huh7.5 cells. J Virol 2013 0.89
26 Hepatitis C virus E2 links soluble human CD81 and SR-B1 protein. Virus Res 2006 0.85
27 Hepatitis C virus-induced mitochondrial dysfunctions. Viruses 2013 0.84
28 Characterization of hepatitis C virus pseudoparticles by cryo-transmission electron microscopy using functionalized magnetic nanobeads. J Gen Virol 2010 0.83
29 The Ig domain protein CD9P-1 down-regulates CD81 ability to support Plasmodium yoelii infection. J Biol Chem 2009 0.83
30 Epstein - Barr virus transforming protein LMP-1 alters B cells gene expression by promoting accumulation of the oncoprotein ΔNp73α. PLoS Pathog 2013 0.83
31 Comparative immunogenicity analysis of modified vaccinia Ankara vectors expressing native or modified forms of hepatitis C virus E1 and E2 glycoproteins. Vaccine 2004 0.81
32 Porcine endogenous retroviruses PERV A and A/C recombinant are insensitive to a range of divergent mammalian TRIM5alpha proteins including human TRIM5alpha. J Gen Virol 2009 0.81
33 Role of seipin in lipid droplet morphology and hepatitis C virus life cycle. J Gen Virol 2013 0.79
34 Hepatitis C virus and its complex interplay with hepatic glucose and lipid metabolism. J Hepatol 2009 0.76
35 The mouse IAPE endogenous retrovirus can infect cells through any of the five GPI-anchored Ephrin A proteins. PLoS Pathog 2011 0.76
36 Batch profiling calibration for robust NMR metabonomic data analysis. Anal Bioanal Chem 2013 0.75